Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Immunotherapy × Sarcoma × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 9 Gastrointestinal 4 Dermatologic 2 Sarcoma 1 Other hematologic neoplasm 1 Gynecologic 1 Breast 1

Conditions

Sarcoma 1 Radiation Injuries 1

Interventions

Radiotherapy 11 Magnetic Resonance Spectroscopy 11 Blood Specimen Collection 11 Ifosfamide 10 Doxorubicin 10 Surveys and Questionnaires 8 Methotrexate 8 Cyclophosphamide 8 fludarabine phosphate 7 Surgical Procedures, Operative 7 Radiosurgery 7 Proton Therapy 6 Cyclosporine 6 Mycophenolic Acid 5 Melphalan 5 Filgrastim 5 Busulfan 5 Biopsy 5 Standard of Care 4 Radiation Dose Hypofractionation 4 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Etoposide 4 Endoscopic Mucosal Resection 4 Early Intervention, Educational 4 Carboplatin 4 Antilymphocyte Serum 4 X-Rays 3 Whole-Body Irradiation 3 Vincristine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07396116 2026-02-12

FUSION-02

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting

Radiation Injuries, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡